Could cancer anti-sickness drug help IBS patients?

2nd March 2020

Could a commonly-prescribed anti-sickness drug be the answer for the 1.3 million people in the UK who struggle with irritable bowel syndrome with diarrhoea (IBS-D)?

A nationwide clinical trial led by researchers at The University of Nottingham and funded by the National Institute for Health Research (NIHR) will assess the medication ondansetron, which is currently used by doctors to help cancer patients cope with the nausea and vomiting associated with chemotherapy, radiotherapy and surgery.

The research will aim to establish whether a much lower dose of the drug could also be a successful treatment for the abdominal pain and urgent bowel movements typically experienced by IBS patients.

The researchers are aiming to recruit 400 adults who have IBS with diarrhoea from more than 20 hospitals across the UK to take part in the research and are appealing for anyone interested in taking part to visit the website to find out whether they are eligible for the study by answering a few simple questions.

Professor Robin Spiller, of the University’s Nottingham Digestive Diseases Centre, said: “Our pilot study suggested this was very valuable for reducing the need for urgent bowel movements which patients find so disruptive of their daily activities, both at work and when they should be relaxing and enjoying life.”

 

 

Half of the volunteers taking part in the 12-week study will be prescribed ondansetron, while the other half will receive a placebo. Participants will be asked to keep a detailed diary and respond to daily text messages to document their symptoms which will help doctors to assess any potential benefits of the new medication.

The trial is being carried out in collaboration with Nottingham University NHS Hospital Trust, as part of the NIHR Nottingham Biomedical Research Centre, and will be run from the Leeds Clinical Trials Research Unit at the University of Leeds.

For more information, click here.

Disclaimer: This publication presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

MORE INFORMATION:

Read more posts...

Your Comments: Mental Health Awareness Week

Digestive symptoms and conditions can have a real impact upon every-day life, that our community sometimes find others can underestimate. Managing pain, being unable to predict symptoms from day-to-day and anxiety surrounding accessing near-by toilet...

22nd May 2020

Mental Health Awareness & Digestive Diseases

Mental Health Awareness Week 2020 falls at a challenging time for many across the globe. The team at Guts UK recognise the impact that digestive diseases can have on your mental health, and this week...

20th May 2020

World IBD Day

On World IBD Day every year, patient organisations come together from all over the globe to raise awareness of Crohn’s disease & Colitis. Guts UK is proud to fund over 10 current active research projects into...

19th May 2020

Eosinophilic Awareness Week 2020

This week, Guts UK wants to raise awareness, encourage collaboration and research into eosinophilic diseases. What are Eosinophilic Diseases? Eosinophilic Diseases (pronounced ee-oh-sin-oh-fil-ik) that affect the gut are identified by the presence of a type...

18th May 2020

World Barrett’s Day

Guts UK is one of the many worldwide charities collaborating to raise awareness of Barrett’s oesophagus for the first ever World Barrett’s Day – 16th May 2020. What is Barrett’s oesophagus? Around 10% of persistent...

16th May 2020

Coeliac Awareness Week – Lockdown as a Coeliac Dietitian

Cristian Costas, coeliac dietitian shares his experience supporting patients with coeliac disease during these challenging times. What was your role before lockdown and COVID-19? I was running the dietetic-led coeliac service at Bradford Teaching Hospitals...

12th May 2020

Cancer Treatment & Covid-19

On Monday, the Health Secretary announced that hospitals are now restarting vital services including cancer care. An important part of our work at Guts UK is campaigning, raising awareness and calling for more research into...

29th April 2020

Creon 25k – Potential Short Term Stock Issues

Guts UK is the only UK charity funding a research fellowship into pancreatitis. Pancreatitis is a priority for our charity, so each November we’re proud to run a month-long Kranky Panky Pancreatitis Awareness Campaign. We...

22nd April 2020

Vitamin D Supplements & Covid19

Vitamin D levels tend to be low in people living in Northern Europe during winter months. Vitamin D is synthesised in the skin by the action of ultraviolet in sunlight. Although it is also present...

26th March 2020

World Digestive Health Day 2020

Happy World Digestive Health Day! Today is a much awaited day on the Guts UK calendar. Guts UK is the only UK charity funding research into the digestive system from top to tail; the gut,...

29th May 2020